Exactly, Howard. Oncosec may just be in position to leapfrog over Big Pharma (Merck, Bristol Myers, Roche)....if they can bypass the need for a checkpoint (KEYTRUDA, OPDIVO, or TECENTRIQ). If Merck were smart they would at the very least sign an exclusive licensing deal with Oncosec if they are not going to buyout the company. This is getting more interesting.....and lets see how Alpha Holdings figures into the mix....they are the largest Oncosec shareholders at this point.